24, Jun 2024
Virat Kohli Reclaims Top Spot in Kroll’s Celebrity Brand Valuation Report with Brand Value of Nearly USD 228 Million
MUMBAI/NEW DELHI: Kroll, the leading independent global risk and financial advisory solutions firm, announced today the launch of the ninth edition of its Celebrity Brand Valuation Study titled, “Brands, Business, Bollywood”. The study provides a ranking of India’s most powerful celebrity brands based on brand values derived from their brand endorsement portfolios and relative social media presence.
The overall brand value of the top 25 Indian celebrities included in the latest study is estimated at $1.9 billion in 2023, an 18% jump from the previous year.
Key findings of the report include:
● Virat Kohli reclaimed the number one spot with a brand value of $227.9 million, nudging Ranveer Singh to second place at $203.1 million.
● Shah Rukh Khan secures third position with a brand value of $120.7 million on the back of three blockbuster hits in 2023, marking his incredible return into India’s top five celebrity endorsers since 2020.
● Akshay Kumar dropped a rank this year to the fourth position with a brand value of $111.7 million while Alia Bhatt moves to fifth with a brand value of $101.1 million.
● Other notable movements include the meteoric rise in brand value of Kiara Advani moving from rank 16 to rank 12, and Katrina Kaif returned to the list of India’s most valued celebrity brands after five years.
Aviral Jain, Managing Director, Valuation Advisory Services at Kroll said, “Our report recognizes the expansion of celebrity-owned startups across various industries and the spectacular rise of Indian celebrities as global ambassadors of reputed global brands. The year 2023 also witnessed Bollywood’s powerful comeback to the film industry, with blockbusters breaking records to cross the $100 million mark—re-establishing Bollywood’s dominance in the film industry. The synergy between celebrity entrepreneurship, global star advocacy and the resurgence of Bollywood is set to redefine the dynamics of the entertainment and business industries.”
About Kroll
As the leading independent provider of risk and financial advisory solutions, Kroll leverages our unique insights, data, and technology to help clients stay ahead of complex demands. Kroll’s team of more than 6,500 professionals worldwide continues the firm’s nearly 100-year history of trusted expertise spanning risk, governance, transactions, and valuation. Our advanced solutions and intelligence provide clients with the foresight they need to create an enduring competitive advantage. At Kroll, our values define who we are and how we partner with clients and communities.
- 0
- By Rabindra
24, Jun 2024
Snakes & Ladders of Life Through Mokshapatta Offers Path to Enlightenment Through Ancient Vedic Wisdom
Renowned life coach and spiritual advisor Swetta Agarwal on Sunday announced the release of her book, “Snakes & Ladders of Life Through Mokshapatta: Discover Karma, Dharma & The Path to Nirvana.”
This insightful work invites readers on an enlightening journey through the depths of ancient Vedic teachings, using the spiritual tool Mokshapatta to navigate life’s complexities and chart a path toward spiritual awakening.
“As we journey through the complex maze of life, ‘Snakes & Ladders of Life Through Mokshapatta’ offers a unique blend of ancient wisdom and practical guidance, helping us understand the intricate dance between karma and dharma,” says author Swetta. “This book is a beacon for those seeking not just spiritual enlightenment but a balanced life where material success complements spiritual growth. It is my hope that readers will find inspiration and clarity, embracing the path to nirvana while fulfilling their worldly responsibilities.”
Also present at the event were Harsh Malhotra, minister of state for Ministry of Corporate Affairs and Road Transport and Highway; Vijay Sampla, former chairman of National Commission for Scheduled Caste; Ram Vilas Das Vedanti Ji, executive chairman Shriram Janam Bhoomi Nyay Samiti; Shilpa Puri, CEO of Summit India, among other dignitaries.
The book delves into the seventy-two levels of awareness and being, providing a comprehensive approach that meets both material and spiritual needs. It emphasizes that true enlightenment does not necessitate renouncing worldly responsibilities but instead integrates them with spiritual growth.
“Snakes & Ladders of Life Through Mokshapatta” is an essential read for anyone fascinated by Vedic wisdom and those seeking practical spiritual guidance. By combining age-old knowledge with contemporary applications, the book ensures readers can achieve both spiritual and material prosperity, leading to a well-rounded and fulfilling life.
24, Jun 2024
Kentico Celebrates 20 Years
Bedford, NH, June 24, 2024 — Creating Kentico: A 20-year evolution Kentico began in 2004 as Petr Palas’ bachelor thesis project, with a simple CMS framework. Just six years later, Kentico became a globally recognized company with offices around the world and 1,781% five-year growth, ranking 4th in Deloitte’s Technology Fast 50–an impressive milestone.five year growth; ranking 4th in Deloitte’s Technology Fast 50–an impressive milestone. In October 2020, Kentico Xperience 13 was released with notable upgrades to the platform. Three years later, Xperience by Kentico was launched as an innovative digital experience platform for clients looking for a single platform that would cover their growing marketing needs.
In 2024, Kentico continues to be recognized as an industry leader for digital experience platforms; offering features guided by customer insights and the expertise of the Kentico team. Today, Kentico is the backbone for over 90,000 websites and counting–-with continued growth on the horizon.
Celebrating success and dedication to a global community
Celebrating 20 years of achievement, Kentico’s team of +250 people, led by CEO Dominik Pinter, gathered to reflect on the company’s journey amidst global and tech industry transformations.
Kentico’s 20 years of success can be attributed to the team spirit which is the core of its company values. Personal and career development are considered fundamental for the growth of the company. Kentico’s achievements can be credited to the tenacity of its team, many of whom have stuck around since the very beginning – thanks to the company’s progressive company culture.
However, employees alone could not create such a strong community. An extensive network of more than 500 digital agencies is the key to turning the Kentico platform into a unique solution for each client. In addition, 11 Most Valuable Professionals (MVPs), who are marketers and developers passionate about Kentico, provide guidance to others and feedback to the Kentico product team.
CEO Dominik Pinter leads the future of Kentico
Dominik Pinter, Kentico’s CEO, is a long- standing employee himself. For Kentico’s 20th anniversary, he reminisced about his journey at Kentico–and the many paths he took within the company. Pinter’s journey began in 2007 as a part-time QA tester while he was still a student. Over the years, he transitioned through different roles at Kentico; from technical leader to product manager. After a four- year hiatus to pursue other opportunities, Pinter returned to Kentico as the vice president of product management. He became the CEO of Kentico in 2022, after the founder Petr Palas stepped away to become a chairman.
Dominik Pinter’s extensive knowledge of Kentico gained from experience within the company has proven to be instrumental as he leads Kentico into the future. With expert leadership and Kentico’s 20 years of success, it’s certain that Kentico will remain a top choice for companies across all industries looking for a reliable DXP.
24, Jun 2024
Tomoko Uno Opens new QHHT Healing Center in Tucson, AZ
Tucson, AZ, June 24, 2024 –Tomoko Uno opened Healing Within, a new QHHT healing center conveniently located on Fort Lowell Rd.
Originally from Japan, Tomoko is a lifelong practitioner of the healing arts, having studied an ancient form of Japanese Shamanism with the Kannagi and Miko (Shinto mystics and healers). Today, Tomoko is a certified QHHT practitioner committed to helping individuals unlock their full potential and achieve holistic wellness. She says, “I’m thrilled to bring QHHT to Tucson and look forward to contributing to the vibrant local healing community. This is a dream come true for me!”
Quantum Healing Hypnosis Technique (QHHT) is a unique and powerful form of hypnosis developed by Dolores Cannon. This technique facilitates access to the subconscious mind, where profound healing and deep insights can be attained. QHHT goes beyond traditional hypnotherapy by exploring past lives and tapping into a higher consciousness that hold answers to life’s most pressing questions.
Fluent in both English and Japanese, Tomoko bridges cultural and linguistic gaps, making her services accessible to the diverse range of clients living in the Tucson area. Her unique background and personal experiences enrich her practice, allowing her to connect with clients on a deep and empathetic level.
As a newcomer to Tucson, Tomoko’s goal is to create a supportive and nurturing environment where clients can explore their inner world and achieve wellness. Tomoko believes in the innate wisdom and healing potential within each person and is dedicated to assisting clients on their journey toward wholeness and empowerment.
Whether working with English-speaking clients or those who prefer Japanese, Tomoko offers private, in-office sessions that last approximately four hours and can be scheduled online at your convenience. The waiting list is currently around 3-4 weeks.
Once per month on weekends, Tomoko can also be found at the Tucson Psychic and Healing Fair located at the Crystal Event Center, 610 W Prince Rd, Tucson, AZ 85705. This is a monthly event with some of the finest healers and readers in Southern Arizona.
24, Jun 2024
Cambridge Polymer Group Unveils Restructure to Accelerate Client Innovation through Material Science
Woburn, MA, June 24, 2024 — Cambridge Polymer Group, Inc. (CPG), a leading contract research laboratory specializing in materials and their commercial applications, announced today a new operating model to meet demand for customized material optimization across the product lifecycle.
Addressing the Evolving Materials Landscape
Increasingly, manufacturers and product designers across all industries are using new materials in novel applications and pushing existing materials into new uses that stretch their performance to the limit. These materials do not always behave as expected, and conventional material specification sheets and standard testing methods are no longer enough.
Today’s successful products can only be obtained through a multi-disciplinary approach, with an emphasis on safety. Developers need deep expertise in materials across industries, along with a thorough understanding of polymer science. This includes the impact of additives, manufacturability (encompassing cleaning and sterilization), biocompatibility, and the intended use of the device or product.
Enhanced Client Collaboration through SME Leadership
To address this growing need for materials expertise, Cambridge Polymer Group is implementing a new five-position management structure. This structure empowers senior Subject Matter Experts to remain at the forefront of client collaboration – a cornerstone of CPG’s successful partnerships. This strategic shift ensures dedicated resources for complex projects, delivering the hands-on materials support clients increasingly require.
Vice President of Research, Dr. Gavin Braithwaite, will step into the newly created position of Chief Executive Officer.
“By staffing our newly designed senior management structure with seasoned scientists, we can ensure the continued delivery of high-quality science to our clients, while placing a stronger emphasis on product development and challenging testing projects,” said Braithwaite. “I am excited to grow the development aspect of our work and build a deeper relationship with our clients, helping them decrease risk, expand into new markets, and increase profitability.”
After 27 years as Cambridge Polymer Group’s President, Dr. Stephen Spiegelberg is moving into the new role of Chief Scientific Officer (CSO). This transition will enable Dr. Spiegelberg to spend more time collaborating with clients and working on large-scale projects in his subject matter expertise, such as biocompatibility, root cause analysis, product development, and medical device cleaning.
“I am personally looking forward to having more scientific interactions with our clients, spending more time on ASTM and AAMI standards development, and studying industry trends to help assist in product development,” said Spiegelberg.
Jaimee Robertson will oversee research operations in the newly created role of Director of Consulting Services, working with CEO Gavin Braithwaite and CSO Stephen Spiegelberg to develop and implement CPG’s research strategy and assist clients in their development projects and root cause analysis work.
Norma Turner will manage lab operations and testing services as Director of Analytical Services, ensuring CPG’s full-service laboratory provides essential support for R&D and consulting projects, as well as value-add to routine analytical testing clients. Norma will be leveraging her extensive experience in ASTM and ISO standards testing to help with both routine and non-routine testing, including residue analysis and extractables and leachables testing.
Dr. Rebecca Bader, Associate Director of Chromatography, will oversee the direction of this critical department and lead CPG’s biocompatibility and risk assessment group. Bader’s material science and analytical chemistry expertise combined with her biocompatibility experience will help clients navigate the challenging regulatory landscape.
Benefits for Clients
· Deeper Collaboration with Material Experts: Clients continue to benefit from close collaboration with CPG’s SMEs.
· Enhanced Support for Complex Projects: The new structure ensures dedicated resources for even the most demanding R&D initiatives.
· Future-Proofed Innovation: CPG is positioned to deliver the advanced materials expertise needed to bring groundbreaking products to market.
24, Jun 2024
American Transformer Solutions Launches in Houston, Offering Comprehensive Transformer Buying Services
Houston, TX, June 24, 2024 — American Transformer Solutions, a new family-owned and operated company, announces its launch in Houston, Texas. The company, founded by an industry expert with over 30 years of experience, specializes in buying a wide range of transformers, serving various industries such as oil and gas, power plants, utility stations, mining, petrochemical, and industrial manufacturing.
American Transformer Solutions is committed to providing a reliable and efficient solution for companies looking to sell their transformers. The company buys padmount, polemount, dry type, and substation transformers, catering to the diverse needs of its clients across multiple industries.
“We started this because we wan to help clean up the environment and stop all the waste,” said Robert Mitlow, the founder of American Transformer Solutions. “With my 30 years of experience, I know we can make a difference by buying up these transformers and putting them to good use.”
By offering a comprehensive transformer buying service, American Transformer Solutions aims to reduce waste and promote sustainability in the industry. The company’s expertise and dedication to environmental responsibility set it apart from competitors in the market.
24, Jun 2024
Future Electronics to Attend FPGA Technology Conference Europe 2024
Pointe Claire, Quebec, Canada, June 24, 2024 — Future Electronics, a leading global distributor of electronic components, will participate in the FPGA Technology Conference in Europe, the premier event dedicated to field programmable gate array (FPGA) technology on the continent. The conference will take place in Munich from July 2 to 4, 2024.
Future Electronics invites attendees to visit their booth (#30) to explore the latest innovations in FPGA technology. Highlights at the booth will include a showcase of the Single Pair Ethernet network demonstration, OPC/UA server integration, and low-latency edge detection/sobel filtering on real-time video streams. Attendees will also have the chance to play “Yoshi’s Nightmare,” an arcade video game running on the PolarFire SoC.Visitors can discuss their project needs with the Future Electronics team for an opportunity to obtain a Renesas SLG47910V Evaluation Board or a Microchip PolarFire SoC Discovery Kit.
During the conference, Dr. Baris Konuk, Afef Zakhama, and Francisco Perez will present two key sessions:
The first session, “Optimizing Power Efficiency in Embedded Vision Systems,” will take place on July 2 from 11:15 to 12:45. This session will provide guidance on optimizing power efficiency in embedded vision applications, covering image processing functionalities and video interfaces while reducing overall power consumption.
The second session, “Artificial Intelligence in Low Power Environments,” will be held on July 3rd from 14:30 to 16:00. This session will demonstrate how specific FPGA technologies can balance performance and low power consumption in machine learning applications.
24, Jun 2024
I Holland Launches Tooling Safe Disposal & Recycling Service
Nottingham, United Kingdom, June 24, 2024 — I Holland, has launched its new Safe Disposal &Recycling Service. This valuable service is designed to ensure the safe, secure, and environmentally responsible destruction of obsolete or worn-out tooling, enhancing both the integrity and sustainability of pharmaceutical manufacturing.
Their commitment to quality and tooling care, through all stages of its lifecycle, is now extended to the end-of-life management of tooling, addressing critical concerns such as data security, compliance, and counterfeiting considerations.
The service ensures the complete and secure destruction of tools to protect proprietary designs and intellectual property. For important processes like these, peace of mind is paramount. Adhering to industry standards and regulations, the service provides full certification and documentation of the destruction process, with the optional choice for the customer to witness the destruction themselves.
With the launch of the Safe Disposal & Recycling Service, I Holland continues to lead the way in supporting the pharmaceutical industry not only by manufacturing high-quality tooling but also facilitating a comprehensive tool lifecycle maintenance routine, which now includes a tool’s end of life.
It offers a streamlined process to minimize downtime and ensure the hassle-free handling of obsolete tools.
This new service comes as an extension of the I Holland tool maintenance procedure, the PharmaCare 7-Steps. The procedure advises on how to keep tooling in good working condition, reducing tablet press downtime, reducing compression problems, and helping to achieve the optimum lifetime and performance of your tablet compression tooling.
24, Jun 2024
Pennington Biomedical Shares Small Shifts for Nutritional Health
Baton Rouge, LA, June 24, 2024 –Once a person decides it’s time to lose some weight, it may be difficult to determine what’s the best option for them. With all the diet noise out there, what’s the best way to take off those unwanted pounds—and keep them off?
The answer lies not in radical changes, say experts at the Pennington Biomedical Research Center, but in small increments. Easy and attainable adjustments, like staying hydrated, opting for more fruits and vegetables and eating mindfully, have a way of snowballing into long-term lifestyle changes that can help shed pounds and boost energy.
“A common misconception is that good nutrition is all or nothing,” says Pennington Biomedical Registered Dietitian Renee Stelzer, Director of the research center’s Metabolic Kitchen. “There’s an old saying, ‘Don’t let perfect get in the way of good,’ and it really applies here.”
As a world-renowned nutrition research center, Pennington Biomedical has been on the forefront of how diet impacts health for decades. With hundreds of studies demonstrating the value of sound nutrition, the research center rolled out its Small Shifts campaign this year to showcase the cumulative value of daily common-sense changes.
“A great place to start is by just making sure you’re eating a variety of fruits and vegetables every day, as well as lean, quality sources of protein,” says Pennington Biomedical Assistant Professor Dr. Jacob Mey, who studies the impact of nutrition on conditions like asthma.
Substituting fruits and veggies for less healthy foods is easy to do both at home and while dining out. Even if finding fresh produce is difficult, frozen fruits and vegetables offer high nutrition value, as do low-sodium, low-sugar canned options, Stelzer says.
Drinking plenty of water is another easy modification, and one that reaps double rewards. It keeps you hydrated, a must for the body’s many functions. And when you substitute water for sugary drinks, it saves you lots of empty calories.
Dr. Mey and Stelzer say integrating mindfulness is also key. Begin to think about what you’re eating and how it makes you feel. Chew slowly. Observe when you start to feel satisfied rather than continuing to eat thoughtlessly.
“Everything in moderation,” Stelzer says. “If you’re mindful at mealtime, the calories will work themselves out.”
Most of all, don’t let “imperfect” behavior derail your overall commitment to living well.
“Even if you make what you consider to be an unhealthy choice, the whole day isn’t ruined,” Dr. Mey says.
To take part in Pennington Biomedical’s “Small Shifts” campaign, people are encouraged to sign up online at pbrc.edu/smallshifts. Upon signing up, participants will receive a free health journal with helpful health resources, a habit tracker, a meal planner and recipes from Pennington Biomedical’s Metabolic Research Kitchen.
Additionally, participants will receive monthly “Small Shifts” messages in which researchers will provide guidance through new small shifts. Participants’ names will also be entered into monthly drawings for giveaways, including water bottles, t-shirts, Bluetooth earphones and other prizes.
24, Jun 2024
The Successful Partnership Between MAIA Biotechnology and Cromos Pharma
Portland, OR, June 24, 2024 — MAIA Biotechnology, a leader in targeted therapy and immuno-oncology, has partnered with Cromos Pharma, a US-based international clinical research organization, to continue making significant strides in cancer treatment research. This collaboration focuses on the development and commercialization of THIO, a novel telomere-targeting agent aimed at treating non-small cell lung cancer (NSCLC) in patients with telomerase-positive cancer cells. This partnership underscores a joint commitment to revolutionizing cancer therapy through innovative approaches.
At the recent ASCO 2024 conference, MAIA unveiled compelling interim clinical data on THIO, capturing significant attention and excitement for its potential to revolutionize cancer therapy. The latest clinical data demonstrates promising disease control, response rates, and benefits post-therapy for THIO.
Key Findings of the Ongoing Phase 2 THIO-101 Clinical Trial:
• Disease Control Rate (DCR): 85% with THIO and Libtayo in NSCLC patients who failed two or more standard-of-care therapy regimens.
• Primary Objectives: Safety and tolerability of THIO, and clinical efficacy measured by overall response rate (ORR).
THIO, combined with Libtayo, shows significant disease control in advanced NSCLC patients, indicating a promising new treatment approach for those who have exhausted other options.
The success at the ASCO 2024 conference stems from a strong collaboration between MAIA Biotechnology and Cromos Pharma. Playing a crucial role in the THIO-101 trial, Cromos Pharma excelled particularly in patient recruitment, successfully enrolling 85% of participants from key European countries—outperforming other regions involved in the trial. They also managed trial sites and secured the necessary regulatory approvals efficiently across these countries, ensuring a smooth and effective progression of the trial.
Cromos Pharma is proud to partner with MAIA in advancing innovative cancer therapies. The company values its role in this noble endeavor and is committed to supporting MAIA’s mission to improve and extend the lives of cancer patients through ongoing collaboration.
About MAIA Biotechnology, Inc.
MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Its lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells.
